Benazepril
Buy now to access the full article, existing subscribers login
Class of drug
- Angiotensin converting enzyme (ACE) inhibitor
.
Uses
Action
- Rapid absorption from the gastrointestinal tract following oral administration; benazepril is then hydrolyzed by the liver to benazeprilat, a highly specific and potent angiotensin converting enzyme (ACE) inhibitor.
- ACE inhibition reduces conversion of inactive angiotensin I into angiotensin II, thus reducing angiotensin II-mediated effects (vasoconstriction of arteries and veins and renal sodium and water retention).
- Lowers blood pressure and cardiac volume loading in heart failure.
- Significantly extends lifespan and improves clinical signs in congestive heart failure (reduced coughing and quality of life improved).
- A single dose produces significant inhibition of plasma ACE for more than 24 hours.
- In cats with renal disease it reduces protein loss in urine and lowers blood pressure.
Indications
- Treatment of congestive heart failure.
- Treatment of hypertension
.
- May be of benefit in certain cases of renal insufficiency. Benazeprilat has significant hepatic metabolism.
Adverse reactions
Effects of overdosage
- May reduce RBC counts at high dose.
Other reported reactions
- Hypotension (weakness, disorientation).
- Hyperkalemia.
- Renal impairment.
- Increased appetite and weight gain in cats.
Investigation of adverse reaction
Treatment
- Reduce dose if signs of hypotension.
- Reduce dose if signs of azotemia.
Sample content only, to unlock the full article
login or buy now